Recently, a potential gene that may affect a person’s risk of developing schizophrenia is CHGB, and its variants on schizophrenia might possibly affect the levels of dopamine via interfering with neurotransmission pathway (Shin et al., 2017). This evidence concerns the gene CHGB and schizophrenia.